companies. 6 Management Discussion and Analysis of Business Operation for FY2019 Bangchak Corporation Plc. | Important Events in 2019 January o Important change in accounting policy from the International
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses
period comparing to year 2018. That was due to an additional of one aircraft under operating lease agreement at the beginning of this year. However, this was partly offset by the fluctuation of foreign
baht or decreased by 27.4 percent compared with the same period last year. That was due to the return of aircraft under wet lease arrangements, together with the fluctuation of foreign exchange rate
decreased from 398.6 million baht in the first quarter of year 2018 to 389.6 million baht in year 2019 due to the return of aircraft under wet lease arrangements, together with the fluctuation of foreign
CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 Q1’19 Q4’19 Q1’20 change change Btmn Btmn Btmn y-on-y q-on-q Sales and service income 10,257 11,258 11,223 9.4% (0.3%) EBITDA* 2,413 2,938 3,278 35.8% 11.6% Net
The financial expenses in 2017 were 16.91 million baht decreased from previous year which were at 7.77 million baht. Comparing in term of percent of revenues, the ratio is not much change. It was at